Prevalence of NAFLD in Patients with Diabetes Mellitus
N
Niharika Samala, MD
Primary Investigator
Overview
What is the purpose of this study?
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of liver disease in the US. Having type 2 diabetes is a known a risk factor for developing NAFLD and people who have NAFLD with diabetes are also at an increased risk of developing liver cirrhosis (severe scarring of the liver). The purpose of this study is to assess the prevalence of NAFLD in people with known type 1 or type 2 diabetes mellitus or insulin resistance.
THIS STUDY IS ENROLLING BY INVITATION ONLY - Prospective participants will be gleaned from the list of patients to be seen in the Endocrinology clinic and will be called prior to their appointment. Additionally, prospective participants will be mailed/emailed a letter describing the study and inviting study participation.
Description
What will happen during the study?
This study can be completed in one visit. Participants will complete three questionnaires about health, alcohol consumption, medications, and food consumption. Researchers will measure the participant's waist, hips, and neck as well as body fat percentage using an In Body machine. Participants will have a FibroScan (similar to an ultrasound) done, bloodwork taken, and medical information reviewed.
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
NAFLD, diabetes mellitus
-
Age: Between 18 Years - 100 Years
-
Gender: All
Inclusion Criteria:
- Ability to provide informed consent
- Confirmed or suspected diagnosis of diabetes mellitus
Exclusion Criteria:
- Inability or refusal to provide informed consent
- Subject is a pregnant or lactating female may participant in the study but may not undergo the Inbody® or the FibroScan®.
- Subject with current, significant alcohol consumption as documented in clinical chart
- Patients with a pacemaker or defibrillator may participate in the study but may not undergo the Inbody® or the FibroScan®.
Updated on
27 Apr 2024.
Study ID: 15433, GI-IIR-DIABETES-CLINIC
Please visit our main page to search for other studies you may be interested in.
If you need help finding a study or have any questions, please contact us at inhealth@iu.edu
